-
Impact of holoprosencephaly, exomphalos, megacystis and increased nuchal translucency on first-trimester screening for chromosomal abnormalities.
Syngelaki A, Guerra L, Ceccacci I, Efeturk T, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:45-48. pdf -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Turning the pyramid of prenatal care.
Nicolaides KH.
Fetal Diagn Ther 2011;29:183-96. -
The 11-13-week scan: diagnosis and outcome of holoprosencephaly, exomphalos and megacystis.
Kagan KO, Staboulidou I, Syngelaki A, Cruz JJ, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;36:10-4. -
The 11-14 week scan.
Nicolaides KH, Heath V, Liao AW.
Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:581-94. -
Screening for fetal abnormalities in multiple pregnancies.
Sebire NJ, Nicolaides KH.
Baillieres Clin Obstet Gynaecol 1998;12:19-36. -
Maternal platelet size as a marker for fetal trisomies 18 and 13.
Thilaganathan B, Meher-Homji NJ, Nicolaides KH.
Prenat Diagn 1995;15:605-8. -
Blood transferrin receptor expression in chromosomally abnormal fetuses.
Thilaganathan B, Meher-Homji NJ, Nicolaides KH.
Prenat Diagn 1995;15:282-4. -
Fetal exomphalos and chromosomal defects: relationship to maternal age and gestation.
Snijders RJ, Sebire NJ, Souka A, Santiago C, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;6:250-5. -
Fetal exomphalos at 11 to 14 weeks of gestation.
Snijders RJ, Brizot ML, Faria M, Nicolaides KH.
J Ultrasound Med 1995;14:569-74. -
Maternal age and gestational age-specific risk for chromosomal defects.
Snijders RJ, Sebire NJ, Nicolaides KH.
Fetal Diagn Ther 1995;10:356-67. -
Fetal mild hydronephrosis and chromosomal defects: relation to maternal age and gestation.
Snijders RJ, Sebire NJ, Faria M, Patel F, Nicolaides KH.
Fetal Diagn Ther 1995;10:349-55. -
Repeatability of measurement of fetal nuchal translucency thickness.
Pandya PP, Brizot ML, Altman D, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:334-7. -
The implementation of first trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
Pandya PP, Goldberg H, Walton B, Riddle A, Shelley S, Snijders RJM, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:20-5. -
Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
Pandya PP, Kondylios A, Hilbert L, Snijders RJM, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:15-9. -
Nuchal translucency thickness and crown-rump length in twin pregnancies with chromosomally abnormal fetuses.
Pandya PP, Hilbert F, Snijders RJM, Nicolaides KH.
J Ultrasound Med 1995;14:565-8. -
Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.
Pandya PP, Snijders RJ, Johnson SP, Brizot ML, Nicolaides KH.
Br J Obstet Gynaecol 1995;102:957-62. -
Neutrophil and monocyte beta 2-integrin expression in trisomic fetuses.
Makrydimas G, Thilaganathan B, Plachouras N, Nicolaides KH.
Prenat Diagn 1995;15:325-7. -
Crown-rump length in chromosomally abnormal fetuses at 10 to 13 weeks' gestation.
Kuhn P, Brizot ML, Pandya PP, Snijders RJ, Nicolaides KH.
Am J Obstet Gynecol 1995;172:32-5. -
Superovulation, IGFBP-1 and birth weight.
Johnson MR, Irvine R, Hills F, Bolton VN, Abbas AA, Brooks AA, Allman AC, Chard T, Nicolaides KH.
Eur J Obstet Gynecol Reprod Biol 1995;59:193-5.